Amicus Therapeutics, Inc. Share Price
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Delayed
Nasdaq
01:30:00 25/04/2026 am IST
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05/05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 29/04 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 454.99Cr 389.74Cr 364.67Cr 333.81Cr 626.48Cr 44TCr 634.75Cr 4.31TCr 1.68TCr 22TCr 1.71TCr 1.67TCr 72TCr | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 469.87Cr 402.49Cr 376.6Cr 344.73Cr 646.97Cr 45TCr 655.52Cr 4.45TCr 1.74TCr 23TCr 1.76TCr 1.73TCr 75TCr | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +1.05% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.4 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01/26 | Fiscal year | Chief Executive Officer | 2,25,000 | 0.0727% | ||
| 02/01/26 | Tax | General Counsel | 43,109 | 0.0139% | ||
| 02/01/26 | Tax | Executive/Senior Manager | 30,007 | 0.0097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +95.81% | +13.11% | 454.99Cr | |
| +1.09% | +3.39% | +3.50% | +25.49% | 5.12TCr | |
| -1.07% | +2.45% | +472.11% | +598.71% | 4.54TCr | |
| +1.84% | +8.24% | +19.79% | +91.78% | 4.2TCr | |
| +1.57% | +9.95% | +40.35% | +21.38% | 4.21TCr | |
| -0.93% | -4.80% | +17.39% | +46.60% | 3.19TCr | |
| -0.47% | +3.04% | - | - | 1.67TCr | |
| +1.28% | +7.86% | +37.63% | +153.66% | 1.71TCr | |
| +0.03% | +3.91% | +5.84% | +35.04% | 1.48TCr | |
| +1.33% | +5.73% | +91.59% | +47.37% | 1.39TCr | |
| Average | +0.63% | +2.89% | +87.11% | +114.80% | 2.8TCr | |
| Weighted average by Cap. | +0.60% | +3.08% | +103.16% | +146.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 53Cr 45Cr 42Cr 39Cr 73Cr 5.05TCr 74Cr 500.27Cr 195.09Cr 2.54TCr 198.37Cr 194.05Cr 8.4TCr | 63Cr 54Cr 51Cr 47Cr 87Cr 6.07TCr 88Cr 600.56Cr 234.2Cr 3.05TCr 238.14Cr 232.96Cr 10TCr |
| Net income | -5.61Cr -4.81Cr -4.5Cr -4.12Cr -7.73Cr -536.82Cr -7.83Cr -53Cr -21Cr -269.67Cr -21Cr -21Cr -891.95Cr | -2.71Cr -2.32Cr -2.17Cr -1.99Cr -3.73Cr -259.39Cr -3.78Cr -26Cr -10Cr -130.3Cr -10Cr -9.96Cr -430.98Cr |
| Net Debt | 19Cr 17Cr 16Cr 14Cr 27Cr 1.85TCr 27Cr 183.42Cr 72Cr 930.99Cr 73Cr 71Cr 3.08TCr | 15Cr 13Cr 12Cr 11Cr 20Cr 1.42TCr 21Cr 140.93Cr 55Cr 715.32Cr 56Cr 55Cr 2.37TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
